The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Grifols Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
8 result(s) found, displaying 1 to 8
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial.
-
Cancellation or suspensionRegulatory action due to The manufacturer requested in writing the revocation of their TGA conformity assessment certificates., effective 20/02/2019
-
Cancellation or suspensionRegulatory action due to The manufacturer requested in writing the revocation of their TGA conformity assessment certificates., effective 20/02/2019
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial (164550)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 10g in 200 mL human normal immunoglobulin solution for intravenous infusion vial.
-
INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial (164551)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 2.5g in 50mL human normal immunoglobulin solution for intravenous infusion vial.